对抗细菌细菌的酸还原酶可激活的拉帕霍尔揭示了抗菌特异性
Ivonne R Lopez-Miranda1,2, Tianyi Ma1,3, Joshua N Milstein1,3
1Department of Chemical & Physical Sciences, University of Toronto Mississauga, Mississauga, Canada.
ChemMedChem
|March 13, 2026
概括
我们开发了一种新型的lapachol前药物来对抗抗菌素耐药性. 这种前药在细菌中选择性地释放lapachol,显示出高效率和对哺乳动物细胞的最小毒性.
科学领域:
- 自然产品化学 自然产品化学
- 抗微生物耐药性 抗微生物耐药性
- 药物开发 药物开发
背景情况:
- 拉帕霍尔具有抗菌性质,但对哺乳动物细胞有毒性,限制了其治疗应用.
- 抗菌素耐药性需要开发新的治疗策略和药物输送系统.
研究的目的:
- 设计和合成一种拉帕霍尔前药物,利用细菌酸还原酶进行向药物释放.
- 评估lapachol前药物对细菌感染的疗效和选择性,同时尽量减少哺乳动物细胞毒性.
主要方法:
- 一种旨在通过基还原酶介导激活的lapachol前药物的合成.
- 在体外研究中使用纯化缩酶和细菌培养物 (细菌细菌) 来证实lapachol的释放.
- 殖民地形成测试以评估细菌毒性和哺乳动物细胞培养以评估细胞毒性.
主要成果:
- 拉帕科尔前药物的成功合成和表征.
- 由细菌酸还原酶在体外和在Bacillus subtilis中从前药物中释放活性拉帕的证明.
- 获得了与自由拉帕霍尔相似的抗菌疗效,对哺乳动物细胞的毒性显著降低 (> 10 倍的选择性).
结论:
- 开发的lapachol前药物为向抗菌疗法提供了一个有前途的战略.
- 这种方法有效地克服了自由拉帕科尔的毒性限制,增强了其治疗细菌感染的潜力.
- 这种前药具有显著的选择性,向细菌,同时保留健康的哺乳动物细胞.
相关概念视频
01:27Phase I Reactions: Reductive Reactions
696
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
696
01:13meta-Directing Deactivators: –NO2, –CN, –CHO, –CO2R, –COR, –CO2H
7.0K
All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
7.0K